The global Injectable Drug Delivery Devices market was valued at US$ 8480.2 million in 2020 and is expected to reach US$ 14720 million by the end of 2027, growing at a CAGR of 8.1% during 2021-2027.
Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effect. These devices are majorly used during treatment of diseases like cancer and diabetes.
Increasing cancer population is the major factor for the growth of the market. Global injectable drug delivery devices market is driven by rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, increasing use of biologics. Technological advancements, improving patient compliance, beneficial reimbursement policies, increasing healthcare awareness and increasing geriatric population has also contributed to the growth of the market. Whereas, risk of blood-borne infections, safety concerns regarding the use of injectable, introduction of the alternative drug delivery devices would restrain the growth of the market.
Global Injectable Drug Delivery Devices Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Injectable Drug Delivery Devices Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are Dickinson and Company, Baxter International, Schott, Eli Lilly, Pfizer, Gerresheimer, Terumo, Antares Pharma, Novo Nordik, Sanofi, Unilife, Zogenix, Hospira, Presage Bioscience, MicroCHIPS, Pearl Therapeutics, Genentech, Bend Research and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Segment by Type
Segment by Application
- Immune Disorder
Table of Content:
1 Injectable Drug Delivery Devices Market Overview
2 Injectable Drug Delivery Devices Market Competition by Manufacturers
3 Injectable Drug Delivery Devices Retrospective Market Scenario by Region
4 Global Injectable Drug Delivery Devices Historic Market Analysis by Type
5 Global Injectable Drug Delivery Devices Historic Market Analysis by Application
6 Key Companies Profiled
7 Injectable Drug Delivery Devices Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Injectable Drug Delivery Devices Market Dynamics
10 Global Injectable Drug Delivery Devices Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta